Kineta, Inc. and RLB Holdings Announce New Joint Venture to Address High-Need Therapeutics Including Autoimmune Diseases
SEATTLE--(BUSINESS WIRE)--Kineta, Inc., a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, LLC, which will commercialize promising, [...]